Glioblastoma Clinical Trials in Miami, FL

Glioblastoma Clinical Trials in Miami, FL

View the best 10 glioblastoma medical studies in Miami, Florida. Access promising new therapies by applying to a Miami-based Glioblastoma clinical trial.

Trials in Miami, Florida

Here are the top 10 medical studies for glioblastoma in Miami, Florida

Image of Children's Hospital of Alabama in Birmingham, United States.

Selpercatinib

Tyrosine Kinase Inhibitor

Recruiting1 awardPhase 2
This trial will test how well selpercatinib works in treating patients with advanced solid tumors, lymphomas, or histiocytic disorders that have activating RET gene alterations.
Image of Carilion Clinic in Roanoke, United States.

Treatment

Recruiting1 awardPhase 2
This trial will look at how well an imaging scan can detect and track cancer activity in people with solid tumors.
Image of City of Hope Comprehensive Cancer Center LAO in Duarte, United States.

Selinexor +1 More

Selective Inhibitor of Nuclear Export

Recruiting1 awardPhase 1 & 2
This trial tests selinexor with temozolomide for patients whose brain cancer has returned. Selinexor blocks a protein that helps cancer cells grow, and temozolomide damages their DNA to kill them or stop their growth. Temozolomide is a DNA methylating drug currently used as a first-line treatment in glioblastoma therapy.
Image of University Health Network Princess Margaret Cancer Center LAO in Toronto, Canada.

Erdafitinib

Kinase Inhibitor

Recruiting1 awardPhase 2
This trial will test a drug (erdafitinib) to see if it can help slow/shrink IDH-WT gliomas with an abnormal FGFR protein.
Image of Hartford Healthcare (Data Collection) in Hartford, United States.

Nivolumab +1 More

Checkpoint Inhibitor

Recruiting1 awardPhase 2
This trial is testing if adding nivolumab to radiation therapy and bevacizumab improves treatment for recurrent glioblastoma.
Image of University of Miami Hospital in Miami, United States.

DB107-RRV +1 More

Virus Therapy

Recruiting1 awardPhase 2
This trial aims to see if a new combination treatment can reduce the size of a type of brain cancer called high-grade glioma in patients with recurrent or progressive disease, whether the tumor can be surgically
Image of Barrow Neurological Institute in Phoenix, United States.

Berubicin +1 More

Anthracenedione

Recruiting1 awardPhase 2
This trial will compare the effect of two cancer drugs, berubicin and lomustine, on overall survival in patients with glioblastoma multiforme (GBM) who have failed standard first line therapy. A futility analysis will be performed after approximately 30-50% of planned patients have completed the primary endpoint at 6 months.
Image of 1004 in Denver, United States.

BDTX-1535

Small Molecule Inhibitor

Recruiting1 awardPhase 1 & 2
This trial is testing a new drug for people with glioblastoma or non-small cell lung cancer who have disease progression following standard of care.
Image of University of Alabama at Birmingham in Birmingham, United States.

DCVax®-L

Dendritic cell immunotherapy

Recruiting1 awardPhase 3
This trial tests DCVax-L, a treatment using a patient's own immune cells, in patients with newly diagnosed GBM undergoing surgery. It aims to train their immune system to better attack brain cancer cells. This treatment is being tested in several clinical trials, with safety and feasibility proven and promising clinical results reported.
Image of University of Southern California in Los Angeles, United States.

Perillyl alcohol

Monoterpene

Recruiting1 awardPhase 1 & 2
This trial is testing NEO100, a purified form of perillyl alcohol, to treat aggressive brain tumors in patients whose cancer has returned or not responded to other treatments. The treatment is given through the nose regularly and may help slow down tumor growth. Perillyl alcohol (POH) is a naturally occurring substance with properties that may inhibit tumor growth, and NEO100 is a highly purified version of POH currently being tested for glioblastoma treatment.

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.